ArticleAntimicrobial agents and chemotherapy2011

Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Antara Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.